Rise in Awareness about Fertility Drugs Expected to Drive Global Fertility Treatments Market: Ken Research

Fertility treatment market comprises of sales services & related products that are used in many applications to treat infertile patients. Fertility treatment is a medical procedure that increases the chances of conceiving a child. This treatment refers to the treatment options used to stimulate the production of sperm or egg. It includes procedures that handle sperm, eggs, or embryos. Fertility drugs are used for treating ovulation disorders that account for 25% of female infertility cases. These drugs stimulate ovulation in females for promoting fertility. Some of the most common fertility drugs include Femara, Clomid, and gonadotropins. Assisted reproductive technologies (ART) include fertility treatments that entail Assisted Reproductive Technologies (ART) refer to the fertility treatments that involve the handling of eggs, sperm or embryos.

According to study, “Fertility Treatments Market Global Report 2020-30” the key companies operating in the global fertility treatments market are Genea Limited, Apollo Hospitals Enterprise Ltd., Care Fertility Group,The Johns Hopkins Health System Corp, Progyny Inc.,, Vitrolife, Medicover Group, Monash IVF Group, Carolinas Fertility Institute, Merck KGaA, Cook Medical, OvaScience Inc., Xytex Cryo International, Cooper Surgical, Inc, Instituto Bernabeu, Virtus Health, CryoChoice, LLC, INVO Bioscience, The Cooper Companies Inc., Millendo Therapeutics, Inc, Fertility Focus, Olympus Corporation, FUJIFILM Irvine Scientific, LABOTECT GMBH, Ferring Pharmaceuticals, Irvine Scientific sales Company, Inc.

Based on product type, fertility treatments market is segmented as equipment and reagents. Based on drug type, market is segmented as Letrozole, Clomiphene Citrate, Hormone Treatment, Serophene, Aromatase Inhibitors, Gonadotrophins, Estrogen Receptor Modulators, Metformin Hydrochloride, Dopamine Agonists and others. Based on gender type, market is segmented as male and female. Based on procedure, market is segmented as artificial insemination, assisted reproductive technology, Hysteroscopy, Laparotomy/Open Surgery, Laparoscopy & Robotic Laparoscopy, Vasectomy Reversal (Vasovasostomy Or Vasoepididymostomy), Egg Retrieval, Varicocelectomy, Sperm Retrieval (Epididymal Aspiration) and others. In addition, based on end-user, market is segmented as hospitals, fertility clinics, clinical research institutes and others.

The fertility treatment market is driven by rise in awareness about fertility drugs, followed by growth in development of effective treatments, and increase in infertility cases. However, high cost of fertility treatments may impact the market. Moreover, poor sperm motility & low sperm count in men and increase in accessibility & availability of healthcare facilities are key opportunities for market. Furthermore, increase in IVF tourism is a major trend for market.

Based on geography, the European and North-American regions hold major share in global fertility treatments market owing to lower fertility rate and increase in the median age of motherhood in the region. The Asian-Pacific region is expected to witness higher growth rate due to increase in obesity cases and decline in fertility rates over the forecast period. It is estimated that future of the global fertility treatments market will be bright as a result of increase in healthcare and research expenditure during the forecast period. The global fertility treatments market was valued at US $14870.3 million in 2019 and it is projected to grow at higher CAGR of 8.90% and reach US $20913.72 million by 2023.

For More Information, Click on the Link Below:-
https://www.kenresearch.com/healthcare/general-healthcare/fertility-treatments-market/342052-91.html

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. Ken Research provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Serving over 70% of fortune 500 companies globally, some of top consulting companies and Market leaders seek Ken Research’s intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.